fig3
![Proteasomal adaptations to FDA-approved proteasome inhibitors: a potential mechanism for drug resistance?](https://image.oaes.cc/777b1aec-4767-48e3-848e-0c11ee5b14c2/4081.fig.3.jpg)
Figure 3. Examples of non-standard 20S proteasomes containing β5i-β1i-β2 or β5i-β1-β2 composition.
Figure 3. Examples of non-standard 20S proteasomes containing β5i-β1i-β2 or β5i-β1-β2 composition.
All published articles will preserved here permanently:
https://www.portico.org/publishers/oae/